Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

被引:319
作者
Riera, Rachel [1 ,2 ,3 ]
Bagattini, Angela Maria [1 ]
Pacheco, Rafael Leite [1 ,2 ,3 ,4 ]
Pachito, Daniela Vianna [1 ]
Roitberg, Felipe [5 ,6 ,7 ]
Ilbawi, Andre [6 ]
机构
[1] Hosp Sirio Libanes, Ctr Hlth Technol Assessment, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo Unifesp, Escola Paulista Med EPM, Discipline Evidence Based Med, Sao Paulo, Brazil
[3] Oxford Brazil EBM Alliance, Petropolis, RJ, Brazil
[4] Ctr Univ Sao Camilo, Sao Paulo, Brazil
[5] Inst Canc Estado Sao Paulo HCFMUSP, Sao Paulo, Brazil
[6] World Hlth Org WHO, Dept Noncommunicable Dis, Geneva, Switzerland
[7] European Soc Med Oncol ESMO, Lugano, Switzerland
关键词
RADIATION ONCOLOGY; IMPACT; OUTBREAK; REORGANIZATION; DEPARTMENTS; EPIDEMIC; LOMBARDY; THERAPY;
D O I
10.1200/GO.20.00639
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE There has been noteworthy concern about the impact of COVID-19 pandemic on health services including the management of cancer. In addition to being considered at higher risk for worse outcomes from COVID-19, people with cancer may also experience disruptions or delays in health services. This systematic review aimed to identify the delays and disruptions to cancer services globally. METHODS This is a systematic review with a comprehensive search including specific and general databases. We considered any observational longitudinal and cross-sectional study design. The selection, data extraction, and methodological assessment were performed by two independent reviewers. The methodological quality of the studies was assessed by specific tools. The delays and disruptions identified were categorized, and their frequency was presented. RESULTS Among the 62 studies identified, none exhibited high methodological quality. The most frequent determinants for disruptions were provider- or system-related, mainly because of the reduction in service availability. The studies identified 38 different categories of delays and disruptions with impact on treatment, diagnosis, or general health service. Delays or disruptions most investigated included reduction in routine activity of cancer services and number of cancer surgeries; delay in radiotherapy; and delay, reschedule, or cancellation of outpatient visits. Interruptions and disruptions largely affected facilities (up to 77.5%), supply chain (up to 79%), and personnel availability (up to 60%). CONCLUSION The remarkable frequency of delays and disruptions in health care mostly related to the reduction of the COVID-19 burden unintentionally posed a major risk on cancer care worldwide. Strategies can be proposed not only to mitigate the main delays and disruptions but also to standardize their measurement and reporting. As a high number of publications continuously are being published, it is critical to harmonize the upcoming reports and constantly update this review. (C) 2021 by American Society of Clinical Oncology
引用
收藏
页码:311 / 323
页数:13
相关论文
共 98 条
[1]   A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives [J].
Achard, Verane ;
Aebersold, Daniel M. ;
Allal, Abdelkarim S. ;
Andratschke, Nicolaus ;
Baumert, Brigitta G. ;
Beer, Karl T. ;
Betz, Michael ;
Breuneval, Thomas ;
Bodis, Stephan ;
de Bari, Berardino ;
Forster, Robert ;
Franzetti-Pellanda, Alessandra ;
Guckenberger, Matthias ;
Herrmannm, Evelyn ;
Huck, Constance ;
Khanfir, Kaouthar ;
Matzinger, Oscar ;
Peguret, Nicolas ;
Pesce, Gianfranco ;
Putora, Paul M. ;
Reuter, Christiane ;
Richetti, Antonella ;
Vees, Hansjorg ;
Vrieling, Conny ;
Zaugg, Kathrin ;
Zimmermann, Frank ;
Zwahlen, Daniel R. ;
Tsoutsou, Pelagia ;
Zilli, Thomas .
RADIOTHERAPY AND ONCOLOGY, 2020, 150 :1-3
[2]   Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety [J].
Alexander, Marliese ;
Jupp, Jennifer ;
Chazan, Grace ;
O'Connor, Shaun ;
Chan, Alexandre .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (05) :1225-1229
[3]  
Alloni R, MINERVA UROL NEFROL, DOI [10.23736/S0393-2249. 20.03923-5, DOI 10.23736/S0393-2249.20.03923-5]
[4]   Implication of COVID-19 in oral oncology practices in Brazil, Canada, and the United States [J].
Alves, Fabio A. ;
Saunders, Deborah ;
Sandhu, Shaiba ;
Xu, Yuanming ;
de Mendonca, Nathalia F. ;
Treister, Nathaniel S. .
ORAL DISEASES, 2021, 27 :793-795
[5]   Additional challenges faced by cancer patients in Gaza due to COVID-19 [J].
AlWaheidi, Shaymaa ;
Sullivan, Richard ;
Davies, Elizabeth A. .
ECANCERMEDICALSCIENCE, 2020, 14
[6]   Changes in radiotherapy practice during COVID-19 outbreak in Turkey: A report from the Turkish Society for Radiation Oncology [J].
Anacak, Yavuz ;
Onal, Cem ;
Ozyigit, Gokhan ;
Agaoglu, Fulya ;
Akboru, Halil ;
Akyurek, Serap ;
Gursel, Bilge ;
Igdem, Sefik ;
Yalman, Deniz ;
Yildiz, Ferah ;
Saglam, Esra Kaytan .
RADIOTHERAPY AND ONCOLOGY, 2020, 150 :43-45
[7]  
[Anonymous], COVID 19 CANC TASKFO
[8]  
[Anonymous], 2017, Checklist for Analytical Cross Sectional Studies
[9]   Impact of COVID-19 on thyroid cancer surgery and adjunct therapy [J].
Bakkar, Sohail ;
Al-Omar, Khaled ;
Aljarrah, Qusai ;
Al-Dabbas, Moh'd ;
Al-Dabbas, Nesrin ;
Samara, Samara ;
Miccoli, Paolo .
UPDATES IN SURGERY, 2020, 72 (03) :867-869
[10]   Delivery of hepato-pancreato-biliary surgery during the COVID-19 pandemic: an European-African Hepato-Pancreato-Biliary Association (E-AHPBA) cross-sectional survey [J].
Balakrishnan, Anita ;
Lesurtel, Mickael ;
Siriwardena, Ajith K. ;
Heinrich, Stefan ;
Serrablo, Alejandro ;
Besselink, Marc G. H. ;
Erkan, Mert ;
Andersson, Bodil ;
Polak, Wojciech G. ;
Laurenzi, Andrea ;
Damink, Stefan W. M. Olde ;
Berrevoet, Frederik ;
Frigerio, Isabella ;
Ramia, Jose M. ;
Gallagher, Thomas K. ;
Warner, Susanne ;
Shrikhande, Shailesh V. ;
Adam, Rene ;
Smith, Martin D. ;
Conlon, Kevin C. .
HPB, 2020, 22 (08) :1128-1134